Affiliation:
1. Tower Health System, Reading Hospital, West Reading, PA 19611, USA
Abstract
Coronavirus disease of 2019 (COVID-19) is the respiratory viral infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite being a primary respiratory illness, it is commonly complicated by systemic involvement of the vasculature leading to arterial and venous thrombosis. In this review, we will focus on the association between COVID-19 and thrombosis. We will highlight the pathophysiology of COVID-19 coagulopathy. The clinical manifestations of COVID-19 vasculopathy will be discussed with a focus on venous and arterial thromboembolic events. COVID-19 vasculopathy and disseminated intravascular coagulation (DIC) are distinguished within, as well as areas of controversy, such as “long COVID”. Finally, the current professional guidelines on prevention and treatment of thrombosis associated with SARS-CoV-2 infection will be discussed.
Reference71 articles.
1. Autopsy findings and venous thromboembolism in patients with COVID-19;Wichmann;Ann. Intern. Med.,2020
2. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis;Klok;Thromb. Res.,2020
3. Pathological changes of the spleen in ten patients with coronavirus disease 2019 (COVID-19) by postmortem needle autopsy;Xu;Zhonghua Bing Li Xue Za Zhi,2020
4. Coronavirus disease 2019 (COVID-19) manifestation as acute myocardial infarction in a young, healthy male;Juthani;Case Rep Infect Dis.,2020
5. Large-vessel stroke as a presenting feature of COVID-19 in the young;Oxley;N. Engl. J. Med.,2020